Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 21, 2026; 32(27): 117715
Published online Jul 21, 2026. doi: 10.3748/wjg.117715
Published online Jul 21, 2026. doi: 10.3748/wjg.117715
Table 1 Characteristics of the study population, n (%)/mean ± SD
| Features | Control (n = 32) | OSA (n = 112) | P value |
| Age (years) | 54.38 ± 8.64 | 58.68 ± 8.64 | 0.014 |
| Gender | 0.015 | ||
| Women | 20 (62.5) | 42 (37.5) | |
| Men | 12 (37.5) | 70 (62.5) | |
| Body mass index (kg/m2) | 28.91 ± 5.54 | 30.34 ± 5.79 | 0.215 |
| Arterial hypertension | 9 (28.1) | 59 (52.7) | 0.016 |
| Previous history of CVD | 1 (3.1) | 12 (10.7) | 0.298 |
| Current smoking | 10 (31.2) | 24 (21.4) | 0.345 |
| Diabetes mellitus type 2 | 2 (6.3) | 16 (14.3) | 0.363 |
| Glucose (mg/dL) | 97.38 ± 13.37 | 105.60 ± 29.92 | 0.071 |
| Insulin levels (μU/L) | 11.54 ± 13.26 | 17.19 ± 13.26 | 0.001 |
| HOMA-IR score | 2.93 ± 2.27 | 5.13 ± 8.20 | 0.001 |
| Glycated Hb (%) | 5.62 ± 0.53 | 5.70 ± 0.74 | 0.668 |
| Triglycerides (mg/dL) | 106.47 ± 66.57 | 138.41 ± 81.74 | 0.006 |
| Total cholesterol | 196.81 ± 39.17 | 192.22 ± 33.73 | 0.514 |
| HDL cholesterol (mg/dL) | 57.53 ± 12.96 | 54.30 ± 18.65 | 0.361 |
| LDL cholesterol (mg/dL) | 115.22 ± 30.75 | 110.21 ± 32.98 | 0.443 |
| VLDL cholesterol (mg/dL) | 21.25 ± 13.24 | 27.45 ± 15.11 | 0.005 |
| Creatinine (mg/dL) | 0.89 ± 0.16 | 0.89 ± 0.18 | 0.847 |
| Glomerular filtration rate (mL/minute/1.73 m2) | 83.98 ± 14.81 | 85.46 ± 16.04 | 0.640 |
| ALT (IU/L) | 18.78 ± 7.34 | 24.71 ± 14.38 | 0.008 |
| AST (IU/L) | 20.28 ± 5.61 | 22.76 ± 11.64 | 0.379 |
| GGT (IU/L) | 22.19 ± 13.03 | 34.46 ± 25.75 | 0.001 |
| Iron (μg/dL) | 78.47 ± 33.50 | 88.28 ± 28.81 | 0.104 |
| Ferritin (ng/mL) | 87.41 ± 72.14 | 143.89 ± 96.55 | 0.003 |
| Transferrin (mg/dL) | 244.26 ± 31.59 | 249.51 ± 36.54 | 0.468 |
| Alkaline phosphatase (IU/L) | 69.63 ± 22.69 | 66.54 ± 18.74 | 0.435 |
| Lactate dehydrogenase (U/L) | 182.72 ± 36.12 | 185.38 ± 36.60 | 0.718 |
| Albumin (g/dL) | 4.38 ± 0.27 | 4.44 ± 0.27 | 0.115 |
| Platelets (109/L) | 226.30 ± 71.27 | 228.20 ± 52.87 | 0.892 |
| C reactive protein (mg/L) | 0.42 ± 0.59 | 0.37 ± 0.41 | 0.953 |
- Citation: Fernández-García CE, Hernández-García MÁ, Aldave-Orzáiz B, Ávalos Pérez-Urría E, Muñoz JM, Friera A, García-Monzón C, Landete P, González-Rodríguez Á. Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea. World J Gastroenterol 2026; 32(27): 117715
- URL: https://www.wjgnet.com/1007-9327/full/v32/i27/117715.htm
- DOI: https://dx.doi.org/10.3748/wjg.117715